Use of Bedside Ultrasonography on the Incidence of Acute Renal Failure in High-risk Surgical Patients

NCT ID: NCT03509935

Last Updated: 2020-07-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

111 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-03-12

Study Completion Date

2019-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The mortality and postoperative complications of high risk surgeries vary in the different series. The management of this group of patients in intensive care unit (ICU) is fundamental to improve these outcomes. The objective of this study will be to evaluate whether the use of bedside ultrasound has an impact on the management of this group of patients with a consequent reduction in the incidence of acute renal failure in ICU and, secondarily, the incidence of associated complications. All adult patients (≥ 18 years old) admitted to ICU at Hospital das Clinicas of UFMG in the immediate postoperative period of major surgery with indication of ICU monitoring will be included and randomly randomized to the control or intervention group. The control group will be conducted by the intensive care physicians in charge without the US, while the second group will be conducted based in US findings. The US protocol will consist of a pulmonary US in four windows in each hemithorax , qualitative assessment of contractility and variation of inferior vena cava diameter. The primary outcome will be the development of acute renal failure as measured by the KDIGO score. Secondary outcomes will be length of ICU and hospital stay, ICU and 28 days mortality, length spent in mechanical ventilation, accumulated water balance, noradrenaline and dobutamine dose. Serum and urinary biomarkers will also be evaluated. Key words: ultrasound, high-risk surgery, intensive care

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a single-center randomized clinical trial to be performed at the Adult Intensive Care Unit (ICU) of the Clinical Hospital of the Federal University of Minas Gerais, Belo Horizonte. The ICU is a clinical-surgical unit that has 18 beds with admission of approximately 100 patients per month, being 70% surgical patients and 30% clinical patients. Postoperative patients who meet the inclusion criteria reported below will be randomized to guide therapy according to ultrasound findings at the bedside versus a group that will not perform this method. Serum and urine samples will be collected in three times: admission (T0), after 12 hours (T1) and after 24 hours (T2) to analysed urine and serum biomarkers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Kidney Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Ultrasound Group

Patients will be submitted to Ultrasound protocol, namely:

1. In the first 6 to 12 hours of admission to ICU
2. Second US after 12-24 hours of inclusion.
3. Third US after 24-48 hours of inclusion.

Protocol:

* US 4 pulmonary quadrants in each hemithorax: anterior and lateral, upper and lower regions.
* US inferior vena cava, collapsability or distensibility index according to the patient's conditions, in spontaneous or controlled ventilation, respectively.
* Cardiac US: subjective evaluation of contractility between normal, reduced or severely reduced.

The US findings will be communicated to the attending physicians who will conduct the patient, according to the protocol, recommending the administration of volume or not, and the use of vasopressors and/or inotropic drugs.

Group Type EXPERIMENTAL

Intervention Ultrasound Group

Intervention Type OTHER

Protocol:

* US 4 pulmonary quadrants in each hemithorax: anterior and lateral, upper and lower regions (figure 1)
* US inferior vena cava, collaborative index or distensibility according to the patient's conditions, in spontaneous or controlled ventilation, respectively.
* Cardiac US: subjective evaluation of contractility in normal, discreetly reduced or severely reduced.

Control Group

Patients randomized to this group will receive care according to the indication of the attending physicians, composed mainly of intensive care physicians, without bedside US. Patients may be submitted to echocardiographic, abdominal and vascular examinations, among others, requested to ultrasound service, according to the indication.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention Ultrasound Group

Protocol:

* US 4 pulmonary quadrants in each hemithorax: anterior and lateral, upper and lower regions (figure 1)
* US inferior vena cava, collaborative index or distensibility according to the patient's conditions, in spontaneous or controlled ventilation, respectively.
* Cardiac US: subjective evaluation of contractility in normal, discreetly reduced or severely reduced.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age equal or superior to 18 years.
* Major surgeries requiring ICU admission associated with one of the following criteria:

* Use of vasoactive drugs
* Use of inotropic drugs
* Mean blood pressure less than 65 mmHg or SBP \<90 mmHg.
* Hyperlactatemia\> 2 mmol / L
* Heart rate\> 90 bpm.
* Invasive mechanical ventilation required for at least 6 hours at the time of inclusion.
* Hypoxia: satO2 \<92% in ambient air.
* Length of surgery greater than 4 hours.
* Request for transfusion of blood products in a surgical block
* Oliguria during procedure, defined as diuresis \<0.5 ml/kg/h.

Exclusion Criteria

Patients who do not agree to the terms of the

* Dying patients with impending death in the first 24 hours
* Patients in a previous renal replacement therapy program
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Federal University of Minas Gerais

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vandack Alencar Nobre

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vandack Nobre, PhD

Role: PRINCIPAL_INVESTIGATOR

Hospital das Clincias UFMG

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital das Clínicas - Universidade Federal de Minas Gerais

Belo Horizonte, Minas Gerais, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

US to guide ressuscitation

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.